Ross C Brownson1,2, Elizabeth A Dodson3, Jon F Kerner4, Sarah Moreland-Russell3. 1. Department of Surgery and Alvin J. Siteman Cancer Center, Washington University School of Medicine, Washington University in St. Louis, St. Louis, MO, USA. rbrownson@wustl.edu. 2. Prevention Research Center in St. Louis, Brown School, Washington University in St. Louis, St. Louis, MO, 63130, USA. rbrownson@wustl.edu. 3. Prevention Research Center in St. Louis, Brown School, Washington University in St. Louis, St. Louis, MO, 63130, USA. 4. Canadian Partnership Against Cancer, Toronto, ON, Canada.
Abstract
PURPOSE: Despite the potential for reducing the cancer burden via state policy change, few data exist on how best to disseminate research information to influence state legislators' policy choices. We explored: (1) the relative importance of core framing issues (source, presentation, timeliness) among policymakers who prioritize cancer and those who do not prioritize cancer and (2) the predictors of use of research in policymaking. METHODS: Cross-sectional data were collected from US state policymakers (i.e., legislators elected to state houses or senates) from January through October 2012 (n = 862). One-way analysis of variance was performed to investigate the association of the priority of cancer variable with outcome variables. Multivariate logistic regression models examined predictors of the influence of research information. RESULTS: Legislators who prioritized cancer tended to rate characteristics that make research information useful higher than those who did not prioritize cancer. Among differences that were statistically significant were three items in the "source" domain (relevance, delivered by someone respected, supports one's own position), one item in the "presentation" domain (telling a story related to constituents) and two items in the "timeliness" domain (high current state priority, feasible when information is received). Participants who prioritized cancer risk factors were 80 % more likely to rate research information as one of their top reasons for choosing an issue on which to work. CONCLUSIONS: Our results suggest the importance of narrative forms of communication and that research information needs to be relevant to the policymakers' constituents in a brief, concise format.
PURPOSE: Despite the potential for reducing the cancer burden via state policy change, few data exist on how best to disseminate research information to influence state legislators' policy choices. We explored: (1) the relative importance of core framing issues (source, presentation, timeliness) among policymakers who prioritize cancer and those who do not prioritize cancer and (2) the predictors of use of research in policymaking. METHODS: Cross-sectional data were collected from US state policymakers (i.e., legislators elected to state houses or senates) from January through October 2012 (n = 862). One-way analysis of variance was performed to investigate the association of the priority of cancer variable with outcome variables. Multivariate logistic regression models examined predictors of the influence of research information. RESULTS: Legislators who prioritized cancer tended to rate characteristics that make research information useful higher than those who did not prioritize cancer. Among differences that were statistically significant were three items in the "source" domain (relevance, delivered by someone respected, supports one's own position), one item in the "presentation" domain (telling a story related to constituents) and two items in the "timeliness" domain (high current state priority, feasible when information is received). Participants who prioritized cancer risk factors were 80 % more likely to rate research information as one of their top reasons for choosing an issue on which to work. CONCLUSIONS: Our results suggest the importance of narrative forms of communication and that research information needs to be relevant to the policymakers' constituents in a brief, concise format.
Entities:
Keywords:
Cancer control; Evidence; Health policy; Policy making; Research
Authors: Jon F Kerner; Janelle Guirguis-Blake; Kevin D Hennessy; Paul J Brounstein; Cynthia Vinson; Randy H Schwartz; Bradford A Myers; Peter Briss Journal: Cancer Causes Control Date: 2005-10 Impact factor: 2.506
Authors: Matthew W Kreuter; Melanie C Green; Joseph N Cappella; Michael D Slater; Meg E Wise; Doug Storey; Eddie M Clark; Daniel J O'Keefe; Deborah O Erwin; Kathleen Holmes; Leslie J Hinyard; Thomas Houston; Sabra Woolley Journal: Ann Behav Med Date: 2007-06
Authors: Rachel G Tabak; Margaret M Padek; Jon F Kerner; Kurt C Stange; Enola K Proctor; Maureen J Dobbins; Graham A Colditz; David A Chambers; Ross C Brownson Journal: Am J Prev Med Date: 2017-03 Impact factor: 5.043
Authors: Coralia Vázquez-Otero; Dinorah Martinez Tyson; Cheryl A Vamos; Nancy Romero-Daza; Jason Beckstead; Ellen M Daley Journal: Cancer Causes Control Date: 2021-04-28 Impact factor: 2.532
Authors: Jonathan Purtle; Félice Lê-Scherban; Paul Shattuck; Enola K Proctor; Ross C Brownson Journal: Implement Sci Date: 2017-06-26 Impact factor: 7.327
Authors: Jonathan Purtle; Félice Lê-Scherban; Xi Wang; Paul T Shattuck; Enola K Proctor; Ross C Brownson Journal: Implement Sci Date: 2018-09-19 Impact factor: 7.327